These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 9307296

  • 1. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO.
    Cancer Res; 1997 Sep 15; 57(18):4075-81. PubMed ID: 9307296
    [Abstract] [Full Text] [Related]

  • 2. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO.
    Endocr Relat Cancer; 2004 Dec 15; 11(4):815-22. PubMed ID: 15613454
    [Abstract] [Full Text] [Related]

  • 3. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE, Shu WP, Kirschenbaum A, Levine AC, Miniati DN, Liu BC.
    Prostate; 1996 Dec 15; 29(6):362-70. PubMed ID: 8977633
    [Abstract] [Full Text] [Related]

  • 4. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
    Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO.
    Br J Cancer; 1999 Sep 15; 81(1):28-36. PubMed ID: 10487609
    [Abstract] [Full Text] [Related]

  • 5. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 6. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C.
    Cancer Res; 2002 Feb 01; 62(3):721-33. PubMed ID: 11830526
    [Abstract] [Full Text] [Related]

  • 7. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
    Soto AM, Lin TM, Sakabe K, Olea N, Damassa DA, Sonnenschein C.
    Oncol Res; 1995 Feb 01; 7(10-11):545-58. PubMed ID: 8866667
    [Abstract] [Full Text] [Related]

  • 8. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK, Grootegoed JA, Blok LJ.
    Endocr Relat Cancer; 2005 Mar 01; 12(1):135-48. PubMed ID: 15788645
    [Abstract] [Full Text] [Related]

  • 9. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA, Naz RK.
    Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Jan 15; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells.
    Chang GT, Steenbeek M, Schippers E, Blok LJ, van Weerden WM, van Alewijk DC, Eussen BH, van Steenbrugge GJ, Brinkmann AO.
    J Natl Cancer Inst; 2000 Sep 06; 92(17):1414-21. PubMed ID: 10974077
    [Abstract] [Full Text] [Related]

  • 12. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Sep 06; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 13. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
    Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzard GS, Mostofi FK, McLeod DG, Moul JW, Srivastava S.
    Proc Natl Acad Sci U S A; 2000 Oct 24; 97(22):12216-21. PubMed ID: 11050243
    [Abstract] [Full Text] [Related]

  • 14. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 24; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 15. TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.
    Gery S, Sawyers CL, Agus DB, Said JW, Koeffler HP.
    Oncogene; 2002 Jul 18; 21(31):4739-46. PubMed ID: 12101412
    [Abstract] [Full Text] [Related]

  • 16. Regulation of S100P expression by androgen.
    Averboukh L, Liang P, Kantoff PW, Pardee AB.
    Prostate; 1996 Dec 18; 29(6):350-5. PubMed ID: 8977631
    [Abstract] [Full Text] [Related]

  • 17. Androgen-independent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression.
    Kanaya J, Takashima M, Koh E, Namiki M.
    Asian J Androl; 2003 Mar 18; 5(1):9-13. PubMed ID: 12646996
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N, Jørgensen PE, Sørensen BS, Nexø E.
    Anticancer Res; 2000 Mar 18; 20(1A):91-5. PubMed ID: 10769639
    [Abstract] [Full Text] [Related]

  • 19. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.
    Drug Metab Dispos; 2007 Jun 18; 35(6):968-72. PubMed ID: 17371798
    [Abstract] [Full Text] [Related]

  • 20. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q, Watson JT, Marengo SR, Decker KS, Coleman I, Nelson PS, Sikes RA.
    Cancer Lett; 2006 Dec 08; 244(2):274-88. PubMed ID: 16500022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.